drugset / Trial / NCT04900220

Differences in Flare Reaction Incidence and Intensity Following Trigger Finger Injections

NCT04900220

Phase 4 Completed 66 enrolled West Virginia University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Two common corticosteroids used for trigger finger treatment are betamethasone and methylprednisolone. Both injections are effective in treating trigger finger and the decision of which to use in treatment is currently a matter of the current practice and physician preference. The goal through this randomized trial is to see whether there is a difference between these two corticosteroids in inducing flare reactions and if there are any differences in the peak level of pain and their duration. Findings indicating a statistically significant difference in the incidence and/or intensity of the flare reactions would be clinically significant and would be evidence supporting the switch of current practice to one corticosteroid over the other.

Timeline

Start
2021-09-15
Primary completion
2022-12-27
Completion
2023-04-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Betamethasone Other / unclassified 6 mg
Comparator Methylprednisolone Other / unclassified 40 mg

Indications

No indication recorded.